Targeting estrogen receptor alpha in breast cancer for novel therapies resistance mechanisms and future directions.

Estrogen receptor α (ERα) is a key therapeutic target in ER-positive breast cancer. Structurally, ERα contains activation function (AF) domains that drives breast cancer proliferation, metastasis, and drug resistance through classical genomic, non-ge…

Preview only. Read the full abstract at the source